<DOC>
	<DOCNO>NCT00002309</DOCNO>
	<brief_summary>To evaluate efficacy safety azithromycin administer week prevention disseminate Mycobacterium avium complex ( MAC ) severely immunocompromised HIV-infected patient CD4 count &lt; 100 cells/mm3 .</brief_summary>
	<brief_title>A Study Azithromycin Prevention Mycobacterium Avium Complex Disease ( MAC ) HIV-Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Required : Antipneumocystis prophylactic therapy ( dihydropteroate synthetase inhibitor without dihydrofolate reductase inhibitor , pentamidine ) . Allowed : Concomitant antiHIV therapy ( AZT , ddI , ddC ) antifungal therapy ( include azoles ) . Patients must : HIV infection . CD4 count &lt; 100 cells/mm3 . No MAC positive blood culture within 1 month prior study entry . No symptoms suggestive disseminate MAC infection ( include unexplained diarrhea , fever , night sweat ) within 1 month study entry . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Positive PPD within 3 month prior study entry ( negative PPD define &lt; 5 mm induration ) . Chest xray suggestive active disease , particular tuberculosis . Known hypersensitivity macrolide antibiotic . Any acute clinical condition likely interfere completion protocol . Inability care self without considerable assistance medical care . Concurrent Medication : Excluded : Other investigational new drug ( except foscarnet ddC ) unless prior agreement reach investigator Pfizer project physician . Concomitant putative immunostimulants . Patients follow prior condition exclude : History MAC Mycobacterium tuberculosis ( MTb ) infection . Prior Medication : Excluded within past 4 week : Any putative antiMAC therapy include rifampin , rifabutin , clofazimine , ethambutol , cycloserine , ethionamide , amikacin , ciprofloxacin quinolones think active MAC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1996</verification_date>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Azithromycin</keyword>
</DOC>